GT
The startup specializes in needle-free disease monitoring using advanced biosensor technology that analyzes biomarkers through the skin. This approach eliminates the discomfort and risks associated with traditional blood sampling, providing a more patient-friendly method for continuous health monitoring.
Updated 20 months ago
Funding
$20.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MFFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup specializes in needle-free disease monitoring using advanced biosensor technology that analyzes biomarkers through the skin. This approach eliminates the discomfort and risks associated with traditional blood sampling, providing a more patient-friendly method for continuous health monitoring.